Differential Impact of the Neutrophil-Lymphocyte Ratio on the Survival of Patients with Stage IV Gastric Cancer

Background and Aim: The neutrophil to lymphocyte ratio (NLR) may be related to progression in several cancers. The aim of this study was to investigate the impact of pretreatment NLR in advanced gastric cancer on the prognosis of the patients stratified by metastatic pattern. Methods: We retrospectively investigated clinical data from 191 patients with stage IV gastric cancer who had undergone surgery for primary gastric cancer between 1997 and 2010 at the Department of Surgical Oncology of Osaka City University. Results: All patients had unresectable metastatic factors including peritoneal metastasis (P) and liver metastasis (H). Sixty-one (32%) patients had more than two unresectable factors. We determined a cutoff value of 2.5 for the NLR to be optimal to discriminate the patient's characteristics and divided patients into low (<2.5) and high (>2.5) NLR group for subsequent analysis. In the low NLR group, long survival was found in patients with H, P, or multiple site metastases. Conclusion: Our results suggest that NLR well reflects the progression of critical metastasis and surgical resection might improve prognosis for patients with low NLR. In conclusion, NLR might be used as a predictive marker to decide on surgical therapy for patients with Stage IV gastric cancer. i 2014 S. Karger AG, Basel

[1]  S. Clarke,et al.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer , 2012, British Journal of Cancer.

[2]  Yibin Kang,et al.  The metastasis-promoting roles of tumor-associated immune cells , 2013, Journal of Molecular Medicine.

[3]  H. Tajiri,et al.  Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma , 2012, British Journal of Cancer.

[4]  S. Lim,et al.  Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer , 2012, Oncology.

[5]  C. Garlanda,et al.  Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.

[6]  H. Shimada,et al.  High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer , 2010, Gastric Cancer.

[7]  S. Ida,et al.  Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer , 2013, Journal of Gastroenterology.

[8]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[9]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[10]  M. Brennan,et al.  Defining palliative surgery in patients receiving noncurative resections for gastric cancer. , 2003, Journal of the American College of Surgeons.

[11]  T. Kubota,et al.  Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer , 2012, British Journal of Cancer.

[12]  M. Choi,et al.  Long‐term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology , 2012, Journal of surgical oncology.

[13]  M. Brennan,et al.  Defining palliative surgery in patients receiving noncurative resections for gastric cancer. , 2004, Journal of the American College of Surgeons.

[14]  D. Jäger,et al.  Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection , 2010, Annals of Surgical Oncology.

[15]  K. Yamagata,et al.  Liver metastasis in gastric cancer with particular reference to lymphatic advancement , 2001, Gastric Cancer.

[16]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[17]  Shahid A. Khan,et al.  A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). , 2012, Journal of hepatology.

[18]  N. Kurumatani,et al.  The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage , 2013, Annals of Surgical Oncology.

[19]  Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.

[20]  C. Lewis,et al.  Neutrophils: key mediators of tumour angiogenesis , 2009, International journal of experimental pathology.

[21]  Y. Maehara,et al.  Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. , 1994, Anticancer research.

[22]  S. Albelda,et al.  Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.

[23]  Y. Kodera,et al.  Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry , 2012, Gastric Cancer.

[24]  Shigemi Matsumoto,et al.  The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.

[25]  P. Tran,et al.  The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma , 2015, American journal of clinical oncology.

[26]  D. McMillan,et al.  Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. , 2012, American journal of surgery.

[27]  C. Antonescu,et al.  Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor , 2013, Annals of Surgical Oncology.

[28]  Y. Kodera,et al.  Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines , 2014, Gastric Cancer.

[29]  Alyssa D Gregory,et al.  Tumor-associated neutrophils: new targets for cancer therapy. , 2011, Cancer research.

[30]  H. Putter,et al.  Value of palliative resection in gastric cancer , 2002, The British journal of surgery.